CVS is getting into the primary care business with the $10.6 billion purchase of Oak Street Health.
The pharmacy chain said the goal of the acquisition is to help customers reduce health costs and improve outcomes, particularly among more at-risk populations.
“Combining Oak Street Health’s platform with CVS Health’s unmatched reach will create the premier value-based primary care solution,” said CVS Health President and CEO Karen S. Lynch. “Enhancing our value-based offerings is core to our strategy as we continue to redefine how people access and experience care that is more affordable, convenient and connected.”
Oak Street Health, founded in 2012, operates 169 medical centers across 21 states and employs 600 primary care providers. Its biggest pool of customers are recipients of Medicare.
The company said the additional resources from CVS will help bolster the company's already technologically-forward approach to health care, as it plans to have over 300 centers by 2026.
“This agreement with CVS Health will accelerate our ability to deliver on our mission and continue improving health outcomes, lowering medical costs, and providing a better patient experience while offering significant value to our shareholders,” said CEO Mike Pykosz.
Over the last decade, CVS has made a number of acquisitions in the healthcare industry. It purchased Omnicare, a nursing home network, for $13 billion in 2015 and Aetna, a nationwide health insurance company, for a whopping $69 billion in 2017.
It had also tried to acquire another primary care provider, One Medical, although Amazon beat it to the punch. The e-commerce company successfully purchased it for $3.5 billion in July.
Atlanta Mayor Andre Dickens shares plans for affordable housing, community-led growth, and why private and public grocery stores could be key to food equity.
Tesla reported a surprise increase in sales in the third quarter as the electric car maker likely benefited from a rush by consumers to take advantage of a $7,500 credit before it expired on Sept. 30. The company reported Thursday that sales in the three months through September rose 7% compared to the same period a year ago. The gain follows two quarters of steep declines as people turned off by CEO Elon Musk’s foray into right-wing politics avoided buying his company’s cars and even protested at some dealerships. Sales rose to 497,099 vehicles, compared with 462,890 in the same period last year.
Tom’s Guide Editor-in-Chief Mark Spoonauer breaks down Apple & Amazon's latest product drops—what's hot, what's hype, and what really matters for users.
InnerPlant CEO Shely Aronov reveals how engineered crops like soybeans and corn emit signals when stressed—offering farmers early warnings to boost yields.
Payoneer CEO John Caplan discusses the implications of $100K H1B visa requirements—and how they could reshape tech talent, hiring, and U.S. competitiveness.
